[HTML][HTML] Chronic cough: new insights and future prospects
A Morice, P Dicpinigaitis, L McGarvey… - European Respiratory …, 2021 - Eur Respiratory Soc
Chronic cough is defined in adults as a cough that lasts for≥ 8 weeks. When it proves
intractable to standard-of-care treatment, it can be referred to as refractory chronic cough …
intractable to standard-of-care treatment, it can be referred to as refractory chronic cough …
Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy
J Baker, C Barnett, L Cavalli, M Dietrich… - Journal of Neurology …, 2021 - jnnp.bmj.com
Communication problems (eg, dysphonia, dysfluency and language and articulation
disorders), swallowing disorders (dysphagia and globus), cough and upper airway …
disorders), swallowing disorders (dysphagia and globus), cough and upper airway …
Risk factors for chronic cough among 14,669 individuals from the general population
Background Risk factors for chronic cough in the general population have not been
described systematically. We identified and ranked chronic cough risk factors at the …
described systematically. We identified and ranked chronic cough risk factors at the …
A randomized, double-blind, placebo-controlled, parallel-group phase 2b trial of P2X3 receptor antagonist sivopixant for refractory or unexplained chronic cough
Introduction To determine the optimal dose of sivopixant, a highly selective P2X3 receptor
antagonist, for refractory or unexplained chronic cough (RCC/UCC). Methods In this phase …
antagonist, for refractory or unexplained chronic cough (RCC/UCC). Methods In this phase …
Chronic cough relief by allosteric modulation of P2X3 without taste disturbance
CR Guo, ZZ Zhang, X Zhou, MY Sun, TT Li… - Nature …, 2023 - nature.com
P2X receptors are cation channels that sense extracellular ATP. Many therapeutic
candidates targeting P2X receptors have begun clinical trials or acquired approval for the …
candidates targeting P2X receptors have begun clinical trials or acquired approval for the …
An update and systematic review on drug therapies for the treatment of refractory chronic cough
NM Ryan, AE Vertigan, SS Birring - Expert opinion on …, 2018 - Taylor & Francis
ABSTRACT Introduction: Chronic Cough (CC) is common and often associated with
significant comorbidity and decreased quality of life. In up to 50% of cases, the cough is …
significant comorbidity and decreased quality of life. In up to 50% of cases, the cough is …
Impaired cough suppression in chronic refractory cough
Functional brain imaging in individuals with chronic cough demonstrates reduced activation
in cortical regions associated with voluntary cough suppression. Little is known about the …
in cortical regions associated with voluntary cough suppression. Little is known about the …
[HTML][HTML] Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough?
Refractory chronic cough (RCC) and unexplained chronic cough (UCC) are common
problems seen in primary care and subspecialty clinics. The role of cough hypersensitivity …
problems seen in primary care and subspecialty clinics. The role of cough hypersensitivity …
Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis
Z Zheng, J Huang, Z Xiang, T Wu, X Lan, S Xie… - …, 2023 - thelancet.com
Background Refractory chronic cough (RCC) has a significant impact on patient's health-
related quality of life and represents a challenge in clinical management. However, the …
related quality of life and represents a challenge in clinical management. However, the …
Heterogeneity of cough hypersensitivity mediated by TRPV1 and TRPA1 in patients with chronic refractory cough
L Long, H Yao, J Tian, W Luo, X Yu, F Yi, Q Chen… - Respiratory …, 2019 - Springer
Background The differential sensitivity of cough to antitussive therapies implies the
existence of heterogeneity in cough hypersensitivity, but how such heterogeneity is …
existence of heterogeneity in cough hypersensitivity, but how such heterogeneity is …